SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MIRA Pharmaceuticals advances oral MIRA-55 toward IND

MIRA Pharmaceuticals said it is advancing non-opioid oral MIRA-55 for inflammatory pain toward an IND.

MIRA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.